AXA Investment Managers’s Dr. Reddy's Laboratories RDY Stock Holding History

AXA Investment Managers’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.24M	Buy	+88,913	New	+$1.28M	﹤0.01%	857

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AXA Investment Managers's RDY Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2025: 88,913 shares worth $1.24M. The stake represents ﹤0.01% of the portfolio and ranks #857 among its holdings.

227 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

AXA Investment Managers held 88,913 shares of Dr. Reddy's Laboratories worth $1.24M as of Q3 2025.
Dr. Reddy's Laboratories was a new AXA Investment Managers position in Q3 2025.
Dr. Reddy's Laboratories made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #857 holding.
227 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.